Huang Yuming, Nong Yanfei, Yang Wah, Lin Xu
Department of Metabolic and Bariatric Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Department of Nephrology, Affilated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Obes Surg. 2025 Aug 9. doi: 10.1007/s11695-025-08149-0.
Obesity is not only a risk factor for chronic kidney disease (CKD) but also accelerates its progression. Metabolic bariatric surgery has been shown to improve the course of CKD significantly. This study aims to explore the impact of metabolic bariatric surgery on renal function from various angles, including pre- and post-operative comparisons, differences between surgical techniques, and subgroup analyses based on kidney function.
We analyzed the outcomes of patients who underwent Roux-en-Y gastric bypass (RYGB) or laparoscopic Sleeve Gastrectomy (LSG) between January 2020 and May 2023 from the prospectively managed database in our hospital. Patients were grouped based on baseline glomerular filtration rate (GFR): hyperfiltration (GFR > 125 mL/min), normal (GFR 125-90 mL/min), CKD stage 2 (GFR 89-60 mL/min), and CKD stage 3 (GFR 59-30 mL/min). Pre- and post-operative outcomes were compared, and subgroup analyses were conducted.
A total of 278 patients were included in the study, with 74.1% undergoing LSG. The cohort was 59.7% female, with an average BMI of 38.3 ± 8.47 kg/m and a mean age of 32.9 ± 9.54 years. Post-operative GFR slightly increased from 115 ± 14.8 mL/min pre-surgery to 118 ± 15.4 mL/min post-surgery. Significant improvements in weight, blood glucose, lipid levels, and blood pressure were also observed. Both RYGB and LSG groups showed significant improvements in renal function post-operatively, with GFR decreasing from 115 ± 18.8 mL/min to 112 ± 16.6 mL/min in the RYGB group and from 119 ± 13.9 mL/min to 115 ± 18.8 mL/min in the LSG group. However, there was no significant difference between the two groups in renal function improvement (P > 0.05). In subgroup analyses, hyperfiltration was present in 29.1% of patients and CKD in 5%. In the hyperfiltration group, GFR decreased from 134 ± 5.49 mL/min to 127 ± 8.46 mL/min, with 40.7% of patients returning to normal GFR levels. However, 8.7% of patients in the normal group developed hyperfiltration, and 4.9% showed signs of renal impairment. Among patients with CKD stage 2 or 3, renal function improved in 50% of cases. Linear regression analysis showed that age, hypertension status, and serum urea levels were significantly associated with postoperative GFR levels (P < .05).
Metabolic bariatric surgery positively impacts renal function one year post-operatively. Preoperative attention to age, hypertension status, and serum urea levels may positively influence patient outcomes. In addition, the potential for postoperative renal insufficiency should be considered, and regular follow-up assessments are essential. Early identification and treatment of abnormalities are crucial for optimizing outcomes.
肥胖不仅是慢性肾脏病(CKD)的危险因素,还会加速其进展。代谢性减重手术已被证明能显著改善CKD的病程。本研究旨在从多个角度探讨代谢性减重手术对肾功能的影响,包括术前和术后比较、手术技术差异以及基于肾功能的亚组分析。
我们分析了2020年1月至2023年5月期间在我院前瞻性管理数据库中接受Roux-en-Y胃旁路术(RYGB)或腹腔镜袖状胃切除术(LSG)的患者的结局。患者根据基线肾小球滤过率(GFR)分组:超滤(GFR>125 mL/min)、正常(GFR 125 - 90 mL/min)、CKD 2期(GFR 89 - 60 mL/min)和CKD 3期(GFR 59 - 30 mL/min)。比较术前和术后结局,并进行亚组分析。
本研究共纳入278例患者,其中74.1%接受LSG。队列中女性占59.7%,平均BMI为38.3±8.47 kg/m²,平均年龄为32.9±9.54岁。术后GFR从术前的115±14.8 mL/min略有增加至术后的118±15.4 mL/min。体重、血糖、血脂水平和血压也有显著改善。RYGB组和LSG组术后肾功能均有显著改善,RYGB组GFR从115±18.8 mL/min降至112±16.6 mL/min,LSG组从119±13.9 mL/min降至115±18.8 mL/min。然而,两组在肾功能改善方面无显著差异(P>0.05)。在亚组分析中, 29.1%的患者存在超滤,5%的患者患有CKD。在超滤组中,GFR从134±5.49 mL/min降至127±8.46 mL/min,40.7%的患者GFR恢复正常水平。然而,正常组中有8.7%的患者出现超滤,4.9%的患者有肾功能损害迹象。在CKD 2期或3期患者中,50%的病例肾功能得到改善。线性回归分析表明,年龄、高血压状态和血清尿素水平与术后GFR水平显著相关(P<0.05)。
代谢性减重手术对术后一年的肾功能有积极影响。术前关注年龄、高血压状态和血清尿素水平可能对患者结局产生积极影响。此外,应考虑术后肾功能不全的可能性,定期随访评估至关重要。早期识别和治疗异常对于优化结局至关重要。